Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ebv-Associated Gastric Cancer; an in Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study From Four Major Provinces of Iran Publisher Pubmed



Abolhasani M1 ; Mohseni AO2 ; Shakeri R3 ; Khavanin A4 ; Khajehei M5 ; Omidi A6 ; Geramizadeh B7 ; Shafigh E8 ; Naghshvar F9 ; Fathizadeh P10 ; Taghizadehgan L11 ; Gharib A12 ; Gulley ML13 ; Dawsey SM14 Show All Authors
Authors
  1. Abolhasani M1
  2. Mohseni AO2
  3. Shakeri R3
  4. Khavanin A4
  5. Khajehei M5
  6. Omidi A6
  7. Geramizadeh B7
  8. Shafigh E8
  9. Naghshvar F9
  10. Fathizadeh P10
  11. Taghizadehgan L11
  12. Gharib A12
  13. Gulley ML13
  14. Dawsey SM14
  15. Malekzadeh R3
  16. Rabkin CS15
  17. Vasei M16
Show Affiliations
Authors Affiliations
  1. 1. Oncopathology Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Dr Mohseni's Pathobiology Laboratory, Iran
  3. 3. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Emergency Medicine Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  5. 5. Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Department of Pathology, Mashhad University of Medical Sciences, Mashhad, Iran
  7. 7. Department of Pathology, Transplantation Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Department of Pathology, Babol University of Medical Sciences, Babol, Iran
  9. 9. Department of Pathology, Mazandaran University of Medical Sciences, Sari, Iran
  10. 10. Department of Pathology and Laboratory Medicine, Apadana Hospital, Ahvaz, Iran
  11. 11. Taghizadegan's Pathology and Laboratory Medicine, Shiraz, Iran
  12. 12. Department of Pathology, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  13. 13. Department of Pathology, University of North Carolina, Chapel Hill, NC, United States
  14. 14. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States
  15. 15. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States
  16. 16. Gene Therapy Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Iranian medicine Published:2024


Abstract

BACKGROUND: Gastric cancer is the fourth leading cause of cancer-related deaths in the world. The identification of gastric cancer subtypes related to recognizable microbial agents may play a pivotal role in the targeted prevention and treatment of this cancer. The current study is conducted to define the frequency of Epstein-Barr virus (EBV) infection in gastric cancers of four major provinces, with different incidence rates of gastric cancers, in Iran. METHODS: Paraffin blocks of 682 cases of various types of gastric cancer from Tehran, South and North areas of Iran were collected. Twelve tissue microarray (TMA) blocks were constructed from these blocks. Localization of EBV in tumors was assessed by in situ hybridization (ISH) for EBV-encoded RNA (EBER). Chi-squared test was used to evaluate the statistical significance between EBV-associated gastric cancer (EBVaGC) and clinicopathologic tumor characteristics. RESULTS: Fourteen out of 682 cases (2.1%) of gastric adenocarcinoma were EBER-positive. EBER was positive in 8 out of 22 (36.4%) of medullary carcinomas and 6 out of 660 (0.9%) of non-medullary type, which was a statistically significant difference (P<0.001). The EBVaGCs were more frequent in younger age (P=0.009) and also showed a trend toward the lower stage of the tumor (P=0.075). CONCLUSION: EBV-associated gastric adenocarcinoma has a low prevalence in Iran. This finding can be due to epidemiologic differences in risk factors and exposures, and the low number of gastric medullary carcinomas in the population. It may also be related to gastric tumor heterogeneity not detected with the TMA technique. © 2024 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.